Biotech Developing Lower Back Pain Remedy Raises $6 Million

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The serial entrepreneur who founded and led pediatric drug developer NextWave Pharmaceuticals which Pfizer acquired last year, is now part of a management team interested in developing a treatment for lower back pain. The condition affects about 31 million people in the U.S., according to the American Chiropractic Association. Mahendra Shah, a venture partner with Vivo Ventures and the executive chairman of Semnur Pharmaceuticals, told MedCity News in a phone interview that the company has raised $6 million as part of a $30 million round to advance its injectable drug for lower back pain.

Help employers find you! Check out all the jobs and post your resume.

Back to news